We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

103 hedge funds and large institutions have $358M invested in iShares US Pharmaceuticals ETF in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

26.87% more ownership

Funds ownership: 96.2% → 123.06% (+27%)

11% more capital invested

Capital invested by funds: $321M → $358M (+$36.7M)

7% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 15

1% more funds holding

Funds holding: 102 → 103 (+1)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

24% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 38

Holders
103
Holders Change
+1
Holders Change %
+0.98%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
16
Increased
29
Reduced
38
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$31.5M
2
LPL Financial
LPL Financial
California
+$10.4M
3
EM
EnTrustPermal Management
New York
+$6.27M
4
Morgan Stanley
Morgan Stanley
New York
+$4.21M
5
UBS Group
UBS Group
Switzerland
+$3.86M

Top Sellers

1
BCM
Brookstone Capital Management
Illinois
-$16.3M
2
BWM
Braver Wealth Management
Massachusetts
-$14.9M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.28M
4
Bank of America
Bank of America
North Carolina
-$3.69M
5
Jane Street
Jane Street
New York
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$48.5M +$4.21M +80,046 +10%
Goldman Sachs
2
Goldman Sachs
New York
$40.4M +$31.5M +599,472 +397%
Bank of America
3
Bank of America
North Carolina
$38.4M -$3.69M -70,074 -9%
LPL Financial
4
LPL Financial
California
$22.1M +$10.4M +197,706 +90%
Wells Fargo
5
Wells Fargo
California
$21.5M -$1.62M -30,813 -7%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$18.8M +$3.17M +60,267 +21%
AWA
7
ARS Wealth Advisors
Florida
$16.8M +$22.6K +429 +0.1%
Brown Advisory
8
Brown Advisory
Maryland
$14.4M +$409K +7,773 +3%
SFI
9
SPC Financial Inc
Maryland
$13M +$650K +12,363 +5%
UBS Group
10
UBS Group
Switzerland
$11.5M +$3.86M +73,401 +53%
ST
11
Spinnaker Trust
Maine
$11M +$650K +12,363 +6%
RJFSA
12
Raymond James Financial Services Advisors
Florida
$7.61M +$3.64M +69,186 +96%
MCM
13
Murphy Capital Management
New Jersey
$6.78M -$19.6K -372 -0.3%
EM
14
EnTrustPermal Management
New York
$6.42M +$6.27M +119,100 New
MFS
15
MSI Financial Services
Massachusetts
$6.27M +$131K +2,490 +2%
TRCT
16
Tower Research Capital (TRC)
New York
$4.93M -$350K -6,645 -7%
RJA
17
Raymond James & Associates
Florida
$4.86M +$151K +2,874 +3%
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$4.53M -$208K -3,945 -4%
MWM
19
MinichMacGregor Wealth Management
New York
$4.18M +$3.73M +70,857 New
AIG
20
American International Group
New York
$3.69M -$944K -17,952 -21%
IA
21
IFP Advisors
Florida
$3.19M +$3.11M +59,109 New
OC
22
Oppenheimer & Co
New York
$2.98M -$60.1K -1,143 -2%
Stifel Financial
23
Stifel Financial
Missouri
$2.56M +$199K +3,792 +9%
CAN
24
Cetera Advisor Networks
California
$2.4M +$72.1K +1,371 +3%
EC
25
Estate Counselors
Wisconsin
$2.4M +$450K +8,550 +24%
1
2 3 4 5

IHE Hedge Fund Activity: Q4 2015 in Review

103 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2015, worth a combined $358M — up 11% from $321M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IHE positions and 15 closed out — a net gain of 1 holder — while 29 added to existing stakes and 38 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $31.5M. The largest seller was Brookstone Capital Management, exiting entirely with an estimated $16.3M sold.

  • 103 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2015, up from 102 in Q3 2015.
  • Funds reported $358M of iShares US Pharmaceuticals ETF stock for Q4 2015, up 11% quarter-over-quarter.
  • 16 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2015 and 15 closed out, a net change of +1 holder.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2015 was Goldman Sachs, an estimated $31.5M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2015 was Brookstone Capital Management, an estimated $16.3M sold.

Based on aggregated 13F filings for Q4 2015.